Navigation Links
23andMe Announces Holiday Season Multi-Pack Discount
Date:12/8/2008

Savings of $200 on 3-Kit Packs; Opportunity for Families to Start Exploring Their Shared Genetics

Mountain View, CA (PRWEB) December 8, 2008 -- 23andMe, Inc., the industry leader in personal genetics, today announced it is offering a Multiple Kit discount through December 31st. Customers who purchase three or more kits in a single order will save $200 on the first three kits and $70 for every additional kit.

By offering this discount, 23andMe hopes to encourage families, in particular, to explore the unique features of the 23andMe Personal Genome Service™ that are of special interest to people who are related. These features allow family members to learn how genetically similar they are and how genes were passed down from grandparents to grandchildren. Some of the special features that are of particular interest to relatives include:

  • Genome View - a visual comparison of two individuals' chromosomes. Siblings can see where they're 100% or 50% similar. Distant cousins can see where their genomes overlap.
  • Grandtree - a pedigree view showing how genes pass through the generations by comparing data from grandparents to grandchildren.
  • Global Similarity - a mapping feature that places individuals in a global context. Over a thousand reference populations provide ancestral perspective and a plot to compare how family members cluster together.

"Family members who enroll in our Personal Genome Service get a richer experience," said Linda Avey, co-founder of 23andMe. "We've designed tools that enable fascinating comparisons for our customers who join 23andMe along with their relatives."

The 23andMe™ service also enables its customers to:

  • Discover how their genes associate with over 95 diseases and traits.
  • Actively participate in an innovative research approach by answering 23andWe surveys.
  • Join discussion groups around areas of interest, including health and ancestry.

Joining the 23andMe Community
To learn more and embark on your own personal genetics journey, please visit: www.23andme.com.

23andMe is now available to consumers in the following locations: Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, the United Kingdom, the United States and Vatican City State.

About 23andMe
23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service™ enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its Series A investors include Genentech, Inc., Google Inc. (NASDAQ: GOOG) and New Enterprise Associates. More information is available at www.23andMe.com.

###

Read the full story at http://www.prweb.com/releases/23andMe/MultiPackDiscount/prweb1714414.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. TIME Magazine Names 23andMe's Personal Genome Service 2008 Invention of the Year
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
23andMe Announces Holiday Season Multi-Pack Discount
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located ... training and leads programs. , In February, 2017, Empower Brokerage introduced their new ... Partners is designed to teach how to maximize their sales efforts, as well ...
(Date:3/24/2017)... ... March 24, 2017 , ... “End Time GPS”: ... events will interrelate. “End Time GPS” is the creation of published author, Wesley ... while working on military munitions and space-vehicle projects. Now, at age ninety-one, he shares ...
(Date:3/24/2017)... ... ... Adventures of Joey, The Dog Who Barks at Puddles”: a boisterous story about a ... God intended. “The Adventures of Joey, The Dog Who Barks at Puddles” is the ... writing, especially about truth and human behavior. , Published by Christian Faith Publishing, Patti ...
(Date:3/23/2017)... Texas (PRWEB) , ... March 23, 2017 , ... The ... 3rd location in the greater Houston Area. The new location is located at 2255 ... Luke’s Hospital in Springwoods Village. This newest location will provide patients living in the ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Mar. 24, 2017 Research and Markets ... the U.S.: Consumer Strategies" report to their offering. ... Pain ... approach and treat their physical pain, emphasizing consumer survey analysis, ... pain sufferers and adults who have selected illnesses/conditions strongly associated ...
(Date:3/24/2017)... , March 24, 2017 ShangPharma, ... high-quality and cost-effective drug development and discovery ... and biotechnology industry, announced today the intent ... ShangPharma will be consolidating the Contract Research ... under Shanghai ChemPartner. These entities include ChemPartner ...
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets ... Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a ... Merck & Co., Inc., Biogen and Sanofi are involved in the development ... of which one is in Phase III stage, 15 are in Phase ...
Breaking Medicine Technology: